bpc-157 fda warning letter compounding issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA cites companies for CGMP

(Dosing Protocol Explained) Most peptide protocols fail at the reconstitution stage, not the injection stage

Nature Chemical Biology 9(5):300-306

Research shows BPC-157 helps safeguard and repair the intestinal lining, which may be valuable for conditions like: Irritable bowel issues Leaky gut and food sensitivities Inflammation-driven gut damage Unlike antacids or symptom-based medications, BPC-157 appears to restore structural integrity to the gut barrier, helping address root causes rather than simply easing discomfort

Side effects: Most patients have no significant side effects

In chronic plantar fasciitis, this organization becomes disrupted, with collagen fibers losing their alignment and the tissue becoming thickened yet weaker